NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Wellumio

Wellumio

Private
WellingtonHealthcare & Life Scienceshttps://www.wellumio.com/

Last Round

VC Round

Feb 11, 2026

Est. Valuation

$14.15M

Total Funding Raised

$9.42M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Wellumio is a medical technology company that develops Axana, a portable, AI-enhanced magnetic resonance-based imaging device designed for the rapid diagnosis of acute stroke.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

portable MRIpoint-of-care MRIstroke diagnosisbedside MRIneuroimagingmedical devicestroke triagemedical imagingpoint-of-care diagnosismobile MRIPulsed Gradient-Free MappingPGFMcontrast-free perfusion imagingpre-hospital diagnosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wellumio Comps

Public and private peers based on sector, stage, and business model.

Wellumio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Wellumio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 11, 2026
Pre SeedNov 2, 2025
SeedAug 24, 2023
GrantSep 1, 2021

Key People

Founding team and executive leadership

Sergei Obruchkov

Co-Founder And Co-CEO, CTO

Founding Team

Shieak Tzeng

Co-Founder CEO

Founding Team

Harry Marfatia

Head of Finance (CFO)

Executive Team

Wellumio Investors

Notable investors and investment history

Wellumio investors
InvestorRounds
Icehouse VenturesVC Round, Seed, Pre Seed
Ministry of Business, Innovation and EmploymentGrant
Snowball EffectVC Round
Outset VenturesPre Seed, Seed
Bridgewest Venture FundPre Seed
Nuance Connected CapitalSeed, VC Round
New Zealand Growth Capital PartnersVC Round, Seed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 28, 2026

    Developing a new product named 'Axana', currently in design and testing phases.

  • Nov 2, 2025

    $3.17M round from Booster Innovation Fund and others

Wellumio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wellumio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wellumio's valuation, stock price, and market status.

Firmographic Details

HeadquartersWellington
Employee Range16
Year Founded2019
Last FundingFeb 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.